Abstract
Thyroxine — binding globulin — slow (TBG-S), a variant found in 4-12% of Black and Pacific Island populations, is inherited as an X-chromosome linked trait. This variant is detected on isoelectric focusing by the characteristic cathodal shift of all its isoforms, suggesting that the difference resides in the core protein. In addition, TBG-S is slightly more thermolabile, which explains why subjects expressing TBG-S have on the average lower serum TBG, and thus reduced T4, concentrations. We now report the molecular basis for this TBG variant, deduced from sequencing the TBG-S gene of an American Black man. Sequencing of the four coding regions and all intron/exon junctions revealed a single nucleotide substitution in the codon for amino acid 171 of the mature protein. The resulting change of the codon GAC to AAC results in replacement of the normal aspartic acid by asparagine. Since the negative charge provided by the aspartic acid is lost when replaced.by the neutral asparagine, this substitution seems responsible for the cathodal shift on isoelectric focusing and slower electrophoretic mobility of TBG-S. An identical nucleotide substitution was identified in an unrelated American Black man expressing TBG-S. Whether the TBG-S phenotype observed in populations from the Pacific Islands is caused by the same mutation remains to be determined.
References
Robbins J., Cheng S.-Y., Gerschengorno M.C., Glinoer D., Cahnmann H.J., Edelnoch H. Thyroxine transport proteins of plasma. Molecular properties and biosynthesis. Rec. Prog. Horm. Res. 84: 477, 1978.
Refetoff S. Thyroid function tests. In: L. J. DeGroot (Eds.), Endocrinology. Grune & Stratton, New York, 1979, p. 387.
Gershengorn M.C., Cheng S.-Y., Lippoldt R.E., Lord R.B., Robbins J. Characterization of human thyroxine-binding globulin. Evidence for a single polypeptide chain. J. Biol. Chem. 252:8713, 1977.
Hocman G. Human thyroxine binding globulin. Rev. Physiol. Biochem. Pharmacol. 81: 45, 1981.
Chandra T., Stackhouse R., Kidd V.J., Robson K.J.H., Woo S.L.C. Sequence homology between human α1-antichy-motrypsin, α1-antitrypsin, and antithrombin III. Biochemistry 22: 5055, 1983.
Long G.L., Chandra T., Woo S.L.C., Davie E.W., Kurachi K. Complete sequence of the cDNA for human α1-antitrypsin and the gene for the S variant. Biochemistry 23: 4828, 1984.
Flink I.L., Bailey T.J., Gustefson T.A., Markham B.E., Morkin E. Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA: closed homology to the serine antiproteases. Proc. Natl. Acad. Sci. (USA) 83: 7708, 1986.
Hammond G.L., Smith C.L., Goping I.S., Underhill D.A., Harley M.J., Reventos J., Musto N.A., Gunsalus G.L., Bardin C.W. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc. Natl. Acad. Sci. (USA) 84: 5153, 1987.
Nikolai T.F., Seal U.S. X-chromosome linked familial decrease in thyroxinebinding globulin deficiency. J. Clin. Endocrinol. Metab. 25: 835, 1966.
Refetoff S., Robin N.I., Alper C.A. Study of four new kindreds with inherited thyroxine-binding globulin abnormalities: possible mutations of a single gene locus. J. Clin. Invest. 51:848, 972.
Burr W.A., Ramsden D.B., Hoffenberg R. Hereditary abnormalities of thyroxine-binding globulin concentration. Q.J. Med. 49:295, 1980.
Trent J.M., Flink I.L., Morkin E., Van Tuinen P., Ledbetter D.H. Localization of the human thyroxine-binding globulin gene to the long arm of the X chromosome (Xq21-22) Am. J. Hum. Genet. 41: 428, 1987.
Daiger S.P., Rummel D.P., Wang L., Cavalli-Sforza L.L. Detection of genetic variation with radioactive ligands. IV. X-linked, polymorphic genetic variation of thyroxin-binding globulin (TBG). Am. J. Hum. Genet. 33: 640, 1981.
Daiger S.P., Wildin R.S. Human thyroxine-binding globulin (TBG): Heterogeneity within individuals and among individuals demonstrated by isoelectric focusing. Biochem. Genet. 19: 673, 1981.
Takamatsu J., Ando M., Weinberg M., Refetoff S. Isoelectric focusing variant thyroxine-binding globulin (TBG-S) in American Blacks: Increased heat lability and reduced concentration in serum. J. Clin. Endocrinol. Metab. 63: 80, 1986
Kamboh M.I., Ferrel R.E. A sensitive immunoblotting technique to identify thyroxine-binding globulin protein heterogeneity after isoelectric focusing. Biochem. Genet. 24: 273, 1986.
Kamboh M.I., Kirwood C. Genetic polymorphism of thyroxin-binding globulin (TBG) in the Pacific area. Am. J. Hum. Genet. 36: 646, 1984.
Whitehouse D.B., Hopkinson D.A., Hill A.V.S., Bowden D.K. Analysis of genetic variation in two human thyroxinebinding plasma proteins by immunodetection after isoelectric focusing. Am. J. Hum. Genet. 49: 259, 1985.
Refetoff S. 1989 (Unpublished).
Refetoff S., Murata Y. X-chromosome — linked inheritance the variant thyroxine-binding globulin in serum of Australian Aborigines: its physical, chemical and biological properties. J. Clin. Endocrinol. Metab. 60: 356, 1985.
Takeda K., Mori Y., Sobieszczyk S., Seo H., Dick M., Watson F., Flink I.L., Seino S., Bell G.I., Refetoff S. Sequence of the variant thyroxine-binding globulin of Australian Aborigines: only one of two amino acid remplacements is responsible for its altered properties. J. Clin. Invest. 83:1344, 1989.
Marshall J.S., Pensky J., Williams S. Studies on human thyroxine binding globulin. VIII. Isoelectric focusing evidence for microheterogeneity of thyroxine binding globulin. Arch. Biochem. Biophys. 156: 456, 1978.
Lasne F., Benzerara O., Lasne Y. Role of sialic acid in the microheterogeneity of serum thyroxine binding globulin. Study by two-dimensional isoelectric focusing. Biochim. Biophys. Acta 708: 49, 1982.
Gartner R., Henze R., Horn K., Pickardt C.R., Scriba P.C. Thyroxine-binding globulin: investigation of microheterogeneity. J. Clin. Endocrinol. Metab. 52: 657, 1981.
Grimaldi S., Bartalena L., Ramacciotti C., Robbins J. Polymorphism of human thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 57:1186, 1983.
Bell G.I., Karam J.H., Rutter W.J. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc. Natl. Acad. Sci. (USA) 78: 5759, 1981.
Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., Mullis K.B., Erlich H.A. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 239: 481, 1988.
Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. (USA) 74: 5463, 1977.
Mori Y., Seino S., Takeda K., Flink I.L., Murata Y., Bell G.I., Refetoff S. A mutation causing reduced biological activity and stability of thyroxine-binding globulin probably as a result of abnormal glycosylation of the molecule. Mol. Endocrinol. 3: 575, 1989.
Ain K.B., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen induced elevation of serum TBG concentration. J. Clin. Endocrinol. Metab. 65: 689, 1987.
Wilson J.M., Kelly W.N. Molecular basis of hypoxanthine-guanine phosphoribosyl-transferase deficiency in a patient with the Lesch-Nyhan syndrome. J. Clin. Invest. 77:1331, 1983.
Menzel H.-J., Assmann G., Rail S.C. Jr., Weisgraber K.H., Mahley R.W. Human apolipoprotein A-l polimorphism: identification of amino acid substitutions in three electrophoretic variants of the Munster-3 type. J. Biol. Chem. 259: 3070, 1984.
Moo-Penn W.F., Je D.L., Johnson M.H., Wilson S.M., Therrell B. Jr., Schmidt R.M. Hemoglobin Tarrant: α126(H9) Asp→Asn. A new hemoglobin variant in the α1β1 contact region showing high oxygen affinity and reduced cooperativity. Biochim. Biophys. Acta 490: 443, 1977.
Ohba Y., Miyaji T., Matsuoka M., Takeda I., Fukuba Y., Shibata S., Ohkura K. Hemoglobin Matsue-Oki: Alpha 75 (EF 4) aspartic acid→asparagine. Hemoglobin 1: 383, 1977.
Brimhall B., Duerst M., Hollán S.R., Stenzel P., Szelényi J., Jones R.T. Structural characterizations of hemoglobins J-Buda [α61 (E 10) Lys→Asn] and G-Pest [α74 (EF 3) Asp→Ans]. Biochim. Biophys. Acta 336: 344, 1974.
Sugihara J., Yokota E., Kagimoto M., Naito Y., Imamura T. Hemoglobin G Waimanalo: α64 (E 13) aspartic acid→asparagine observed in a Japanese family. Hemoglobin 8: 79, 1984.
Takamatsu J. Refetoff S., Charbonneau M., Dussault J.H. Two new inherited defects of the thyroxine-binding globulin (TBG) molecule presenting as partial TBG deficiency. J. Clin. Invest. 79:833, 1987.
Murata Y., Takamatsu J., Refetoff S. Inherited abnormality of thyroxine-binding globulin with no demonstrable thyroxine-binding activity and high serum levels of denatured thyroxine-binding globulin. N. Engl. J. Med. 314:694, 1986
Murata Y., Refetoff S., Same D.H., Dick M., Watson F. Variant thyroxine-binding globulin in serum of Australian Aborigines: its physical, chemical and biological properties. J. Endocrinol. Invest. 8: 225, 1985.
Mori Y., Takeda K., Charbonneau M., Refetoff S. Cloning, and analysis of the coding sequence of the thyroxine-binding globulin (TBG) gene from a subject with inherited complete TBG deficiency. J. Clin. Endocrinol. Metab. 70: 804, 1989.
Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., Carell R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336: 257, 1988.
Refetoff S. Inherited thyroxine-binding globulin (TBG) abnormalities in man. Endocr. Rev. 10:275, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waltz, M.R., Pullman, T.N., Takeda, K. et al. Molecular basis for the properties of the thyroxine-binding globulin-slow variant in American Blacks. J Endocrinol Invest 13, 343–349 (1990). https://doi.org/10.1007/BF03349576
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349576